What is InflaRx N.V. (IFRX) stock price today?

InflaRx N.V. (IFRX) currently trades at $1.98 per share. The stock has a market capitalization of $116.39M and a P/E ratio of —x.

Is IFRX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, InflaRx N.V. has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is InflaRx N.V.'s revenue and earnings?

InflaRx N.V. has trailing twelve-month (TTM) revenue of $29330.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.80.

IFRX

InflaRx N.V.

NASDAQ: IFRX · HEALTHCARE · BIOTECHNOLOGY

$1.98

+18.56% today

Updated 2026-04-29

Market cap

$116.39M

P/E ratio

—

P/S ratio

3,968.21x

EPS (TTM)

$-0.80

Dividend yield

—

52W range

$1 – $2

Volume

0.8M

Market cap

$116.39M

P/E ratio

—

P/S ratio

3,968.21x

EPS (TTM)

$-0.80

Dividend yield

—

52W range

$1 – $2

Volume

0.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

4.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$8.59

+333.84%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-4.71M

- Revenue declining -80.80% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$63089.00	$165789.00	$28173.00	$29330.00
Net income	$-30.99M	$-42.67M	$-46.06M	$-43.83M	$-8.84M
EPS	—	—	—	—	$-0.80
Free cash flow	$-33.91M	$-37.89M	$-48.60M	$-34.03M	$-4.71M
Profit margin	—	-67,630.69%	-27,784.96%	-155,584.20%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IFRX	$116.39M	29	3.7	4.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

InflaRx N.V. trades at $1.98. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $29330.00.

Frequently asked questions

What is InflaRx N.V.'s stock price?

InflaRx N.V. (IFRX) trades at $1.98.

Is InflaRx N.V. overvalued?

Smart Value Score 29/100 (Grade F, Strong Sell).

What is the price target of InflaRx N.V. (IFRX)?

The analyst target price is $8.59, representing +333.8% upside from the current price of $1.98.

What is InflaRx N.V.'s revenue?

TTM revenue is $29330.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio3,968.21x

ROE-88.60%

Beta1.51

50D MA$1.04

200D MA$1.11

Shares out0.07B

Float0.06B

Short ratio—

Avg volume0.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

IFRX vs LLY →IFRX vs JNJ →IFRX vs ABBV →Stock screener →